Pneumococcal Conjugate Vaccine

2

Review clinical trials related to Pneumococcal Conjugate Vaccine. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.

Participants needed: 2,500
Trial details
Age: 1-18Biological sex: AllType: ObservationalSponsor: Association Clinique Thérapeutique Infantile du val de MarneUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Isolate of Streptococcus pneumoniae from at least one blood culture, or pleural...

Pneumococcal strain not transmetted to National Reference Center for Pneumococci...

Status: Recruiting

National Bacterial Meningitis Study in Children and Newborns

Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.

Participants needed: 10,000
Trial details
Age: 1-18Biological sex: AllType: ObservationalSponsor: Association Clinique Thérapeutique Infantile du val de MarneUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF)... [+1]